Advertisement

Topics

Grunenthal Ltd Company Profile

10:46 EDT 20th September 2017 | BioPortfolio


News Articles [15 Associated News Articles listed on BioPortfolio]

Grunenthal buys Adhesys Medical

To continue diversifying its business beyond pharmaceuticals, Grunenthal GMBH acquired privately held surgical sealant firm Adhesys Medical GMBH. Financial details were not disclosed.

AZ sells migraine drug rights to Grunenthal for $300m

AstraZeneca has sold rights to its Zomig migraine drug to Grunenthal in a deal worth up to $302 million. The deal is part of AZ's ongoing tactic of selling off rights to older products to plump up it...

Grunenthal GmbH Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 14062017] Prices from USD $350

Grunenthal GmbH Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Grunenthal GmbH Mergers Acquisitions MA, Partnerships Alliances and Investments report inc...

Grunenthal Opens Innovation Hub In Boston As Next Step In Strategy To Drive External Innovation In Pain, Specialty Therapeutics And Medical Devices Forward

  Life Sciences Jobs   ...

INTAC® - Grunenthal Group presents data demonstrating the strength of its tamper resistant technology at the American Association of Pharmaceutical Science Annual Meeting and Exposition.

BEDMINSTER, N.J. and AACHEN, Germany, Oct. 16, 2012 /PRNewswire/ -- Grunenthal, a global family-owned pharmaceutical company specializing in pain management, today announced that data wil...

AstraZeneca sells migraine drug for up to $302 million

LONDON (Reuters) - AstraZeneca continued its program of divesting old medicines on Wednesday with the sale for up to $302 million of migraine drug Zomig to Germany's Grunenthal.

Grunenthal GmbH Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 10052017] Prices from USD $250

SummaryGrunenthal GmbH Grunenthal is a researchoriented pharmaceutical company. The company researches, develops, produces and markets products for the treatment of pain and innovative formulations of...

Grunenthal GmbH Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27072017] Prices from USD $250

SummaryGrunenthal GmbH Grunenthal is a researchoriented pharmaceutical company. The company researches, develops, produces and markets products for the treatment of pain and innovative formulations of...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Continuous Postoperative Use of Low-Dose Combined Oral Contraceptivesfor for Endometriosis-Related Chronic Pelvic Pain

Because ovarian sex steroids fluctuations during the menstrual cycle are implicated in the pathogenesis of the endometriosis-related chronic pelvic pain (CPP), the oral contraceptives (OCs...

Companies [3 Associated Companies listed on BioPortfolio]

Grunenthal GmbH, Aachen

Grunenthal is an expert in pain therapy and gynaecology and a pioneer in intelligent, user-friendly drug delivery technologies. The company discovers, develops, produces and markets high therapeut...

Grunenthal Ltd

Grünenthal GmbH

Nil

More Information about "Grunenthal Ltd" on BioPortfolio

We have published hundreds of Grunenthal Ltd news stories on BioPortfolio along with dozens of Grunenthal Ltd Clinical Trials and PubMed Articles about Grunenthal Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Grunenthal Ltd Companies in our database. You can also find out about relevant Grunenthal Ltd Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record